← Back to patent-cliff list

CAS 108-01-0

N,N-DimethylaminoethanolN,N-Dimethyl-2-hydroxyethylamine2-(dimethylamino)ethanol

Codes: Tetracaine-003, BPI-7711-002

Application context (from source-drug indications)

AnaesthesiaOxymetazoline Hydrochloride/Tetracaine HydrochloridePeriapical periodontitisOxymetazoline Hydrochloride/Tetracaine HydrochlorideDental cariesOxymetazoline Hydrochloride/Tetracaine HydrochlorideAnaesthesiaTetracaine HydrochlorideRetinitis pigmentosaTetracaine HydrochloridePainTetracaine HydrochlorideNon-small cell lung cancerRezivertinib Mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Oxymetazoline Hydrochloride/Tetracaine HydrochlorideTier C — Watch / trade-
Tetracaine HydrochlorideTier C — Watch / trade-
Rezivertinib MesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Oxymetazoline Hydrochloride/Tetracaine HydrochlorideOptimised routesteps: 3total yield: 93.5g(Tetracaine)
4-Aminobenzoic acid→Butanal→N,N-Dimethyl-2-hydroxyethylamine

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.